Persistence and adherence to HDM SLIT in Japanese children with allergic rhinitis: A multicenter, prospective, observational study.

Persistence and adherence to HDM SLIT in Japanese children with allergic rhinitis: A multicenter, prospective, observational study. - Persistence and adherence to HDM SLIT in Japanese children.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040007

Enrollment

1000

Registered

2020-04-01

Start date

2020-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children aged 5 to 12 years old who start HDM SLIT with Miticure for allergic rhinitis from April 2020 to March 2022.

Exclusion criteria

Exclusion criteria: 1: Patients who have received dust mite immunotherapy. 2: Patients receiving biologic therapy at the start of Miticure administration. 3: Patients who have been receiving systemic steroids for more than 28 days at the start of Miticure administration. 4: Patients considered ineligible by the principal investigator.

Design outcomes

Primary

Measure	Time frame
Persistence rate of HDM SLIT.	—

Secondary

Measure	Time frame
1: Factors associated with HDM SLIT persistence. 2: Factors associated with clinical effects. 3: Sensitization status at the start of HDM SLIT. 4: Factors associated with changes in sensitization status after HDM SLIT.	—

Countries

Japan

Contacts

Public ContactAyako Nigo

Tokyo Metropolitan Children's Medical Center Department of General Pediatrics

ayako_nigo@tmhp.jp0423005111

Outcome results